Logo

Empire Genomics Licenses Affy's Microarray Patents for Dx Development

Sep 07, 2007
NEW YORK (GenomeWeb News) — Affymetrix has licensed several of its microarray-related patents to Empire Genomics, Affy said today.
 
Under the non-exclusive agreement, Empire Genomics, a Buffalo, NY-based molecular diagnostics company, will use Affy’s technology to manufacture, use, and sell DNA chips and related products and services for comparative genomic hybridization, Affy said.
  
Financial terms of the agreement were not released.

Breaking News
The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.